Lb Pharmaceuticals (LBRX) Gains from Investment Securities (2024 - 2026)

Lb Pharmaceuticals' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 2449.58% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (changed N/A YoY), while the FY2025 annual figure was $2.6 million, up 466.3% from the prior year.
• Gains from Investment Securities was $3.0 million for Q1 2026 at Lb Pharmaceuticals, up from $119000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $3.0 million in Q1 2026 to a low of $119000.0 in Q1 2025.
• Historically, Gains from Investment Securities has averaged $1.7 million across 3 years, with a median of $1.8 million in 2024.
• Biggest YoY gain for Gains from Investment Securities was 2449.58% in 2026; the steepest drop was 2449.58% in 2026.
• A 3-year view of Gains from Investment Securities shows it stood at $1.8 million in 2024, then slumped by 93.43% to $119000.0 in 2025, then surged by 2449.58% to $3.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $3.0 million (Q1 2026), $119000.0 (Q1 2025), and $1.8 million (Q4 2024), per Business Quant data.